S&P 500 7,568.92 +0.36%
Nasdaq 25,372.01 +0.83%
S&P/TSX 35,532.28 −0.75%
Apple 331.90 −1.90%
Nvidia 206.69 +2.29%
Microsoft 520.99 +2.74%
Shopify 200.19 −8.02%
Royal Bank 285.42 −0.28%
CAD/USD 0.7157 +0.07%
CLOSED · 00:10 ET
Market ClerkRecap
Wed Nov 4 · markets closed3 signals on Nov 3175 insider buys this week · $365.2MCIRO short report next: Nov 14The week ahead
RM
INSIDER · KNSA · Kiniksa Pharmaceuticals International, plc · CHIEF FINANCIAL OFFICER

Ragosa Mark

Every open-market transaction filed under this name, Nov 2 to Nov 2.

Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$3.4M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHIEF FINANCIAL OFFICERSell220$94.01$21K—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHIEF FINANCIAL OFFICERSell12,034$93.13$1.1M—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHIEF FINANCIAL OFFICERSell10,502$92.03$966K—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHIEF FINANCIAL OFFICERSell14,027$91.40$1.3M—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.